EU anti-counterfeiting law approved, but much work still to be done
This article was originally published in Scrip
Executive Summary
The European Parliament has finally approved the directive on tackling the trade in counterfeit medicines, after several months of discussions with the Council of Ministers over the final shape of the legislation. Stakeholders including the pharmaceutical industry and wholesalers have broadly welcomed the vote, albeit with some reservations on issues such as product pack verification.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.